NO20084852L - MGLUR5 modulatorer V - Google Patents

MGLUR5 modulatorer V

Info

Publication number
NO20084852L
NO20084852L NO20084852A NO20084852A NO20084852L NO 20084852 L NO20084852 L NO 20084852L NO 20084852 A NO20084852 A NO 20084852A NO 20084852 A NO20084852 A NO 20084852A NO 20084852 L NO20084852 L NO 20084852L
Authority
NO
Norway
Prior art keywords
mglur5 modulators
mglur5
modulators
novel compounds
therapy
Prior art date
Application number
NO20084852A
Other languages
English (en)
Norwegian (no)
Inventor
Abdelmalik Slassi
Tao Xin
Tomislav Stefanac
Louise Edwards
Karolina Nilsson
Methvin Isaac
Peter Dove
Andreas Wallberg
Kenneth Granberg
Saswati Ghosal
Original Assignee
Nps Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nps Pharma Inc filed Critical Nps Pharma Inc
Publication of NO20084852L publication Critical patent/NO20084852L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20084852A 2006-05-05 2008-11-18 MGLUR5 modulatorer V NO20084852L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79766306P 2006-05-05 2006-05-05
PCT/US2007/067371 WO2007130824A2 (en) 2006-05-05 2007-04-25 Fused heterocylic compounds and their use as mglur5 modulators

Publications (1)

Publication Number Publication Date
NO20084852L true NO20084852L (no) 2009-01-14

Family

ID=38668441

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084852A NO20084852L (no) 2006-05-05 2008-11-18 MGLUR5 modulatorer V

Country Status (19)

Country Link
US (1) US20070259860A1 (zh)
EP (1) EP2027129A2 (zh)
JP (1) JP2009536213A (zh)
KR (1) KR20090018935A (zh)
CN (1) CN101484455A (zh)
AR (1) AR060811A1 (zh)
AU (1) AU2007248292A1 (zh)
BR (1) BRPI0710980A2 (zh)
CA (1) CA2650255A1 (zh)
CL (1) CL2007001178A1 (zh)
EC (1) ECSP088884A (zh)
IL (1) IL194815A0 (zh)
MX (1) MX2008013834A (zh)
NO (1) NO20084852L (zh)
RU (1) RU2008141511A (zh)
TW (1) TW200808800A (zh)
UY (1) UY30308A1 (zh)
WO (1) WO2007130824A2 (zh)
ZA (1) ZA200809019B (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200821305A (en) 2006-10-05 2008-05-16 Astrazeneca Ab MGluR5 modulators
WO2009054790A1 (en) * 2007-10-26 2009-04-30 Astrazeneca Ab Amide linked heteroaromatic derivatives as modulators of mglur5
WO2009054786A1 (en) * 2007-10-26 2009-04-30 Astrazeneca Ab 1,2,4-triazole aryl n-oxides derivatives as modulators of mglur5
WO2009054787A1 (en) * 2007-10-26 2009-04-30 Astrazeneca Ab 1,2,4-triazole carboxylic acid derivatives as modulators of mglur5
TW200922586A (en) * 2007-10-26 2009-06-01 Astrazeneca Ab Thiophene 1,2,4-triazole derivatives as modulators of mGluR5
WO2009054785A1 (en) * 2007-10-26 2009-04-30 Astrazeneca Ab 1,2,4-triazole ether derivatives as modulators of mglur5
EA201000656A1 (ru) * 2007-10-26 2010-12-30 Астразенека Аб Аминопроизводные 1,2,4-триазола в качестве модуляторов mglur5
WO2009054791A1 (en) * 2007-10-26 2009-04-30 Astrazeneca Ab Fused pyrrolidine 1,2,4-triazole derivatives as modulators of mglur5
WO2010071558A1 (en) * 2008-12-18 2010-06-24 Astrazeneca Ab New process for the preparation of 1- [5- (3-chloro-phenyl) - isooxazol-3-yl] -ethanone and (r) -1- [5- (3-chloro-phenyl) - isooxazol-3-yl] -ethanol
JP5620129B2 (ja) * 2009-03-19 2014-11-05 富士フイルム株式会社 光学フィルム、位相差板、楕円偏光板、液晶表示装置、及び化合物
US20120142672A1 (en) 2009-07-13 2012-06-07 Tatsuki Koike Heterocyclic compound and use thereof
EP2519521B1 (en) * 2009-12-29 2013-11-20 Eli Lilly and Company Tetrahydrotriazolopyridine compounds as selective mglu5 receptor potentiators useful for the treatment of schizophrenia
KR20130139895A (ko) 2010-09-02 2013-12-23 다케다 야쿠힌 고교 가부시키가이샤 경도인지 장애의 치료 또는 예방용 융합 트리아졸
RU2644769C2 (ru) 2013-01-23 2018-02-14 Астразенека Аб Химические соединения
EP2857387A1 (en) 2013-10-07 2015-04-08 Boehringer Ingelheim International Gmbh Process for manufacturing 1,6-dihydro-6-oxo-4-pyridazine carboxylic acid
TW202208347A (zh) 2020-05-06 2022-03-01 德商拜耳廠股份有限公司 作為殺蟲劑之新穎雜芳基三唑化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376553B1 (en) * 1999-03-19 2002-04-23 Knoll Pharmaceutical Company Treatment of pain
MXPA05001592A (es) * 2002-08-09 2005-05-05 Astrazeneca Ab Oxadiazoles como moduladores de receptor-5 de glutamato metabotropico.
CA2495179A1 (en) * 2002-08-09 2004-02-19 Astrazeneca Ab Compounds having an activity at metabotropic glutamate receptors
MY145075A (en) * 2004-02-18 2011-12-15 Astrazeneca Ab Tetrazole compounds and their use as metabotropic glutamate receptor antagonists.
US7585881B2 (en) * 2004-02-18 2009-09-08 Astrazeneca Ab Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
ES2309718T3 (es) * 2004-02-18 2008-12-16 Astrazeneca Ab Compuestos heterociclicos condensados y su uso como antagonistas de los receptores metabotropicos para el tratamiento de trastornos gastrointestinales.

Also Published As

Publication number Publication date
TW200808800A (en) 2008-02-16
CA2650255A1 (en) 2007-11-15
UY30308A1 (es) 2007-11-30
US20070259860A1 (en) 2007-11-08
ZA200809019B (en) 2009-08-26
BRPI0710980A2 (pt) 2011-05-31
IL194815A0 (en) 2009-08-03
CL2007001178A1 (es) 2008-01-18
AU2007248292A1 (en) 2007-11-15
KR20090018935A (ko) 2009-02-24
WO2007130824A2 (en) 2007-11-15
WO2007130824A3 (en) 2008-05-22
AR060811A1 (es) 2008-07-16
MX2008013834A (es) 2008-11-10
ECSP088884A (es) 2008-12-30
CN101484455A (zh) 2009-07-15
EP2027129A2 (en) 2009-02-25
AU2007248292A8 (en) 2008-12-04
JP2009536213A (ja) 2009-10-08
RU2008141511A (ru) 2010-06-20

Similar Documents

Publication Publication Date Title
NO20084852L (no) MGLUR5 modulatorer V
NO20084850L (no) MGLUR5 modulatorer I
NO20084924L (no) N-(2-thiazolyl)-amid derivater som GSK-3 inhibitorer
BRPI0915084B8 (pt) composto, e, composição farmacêutica
EA200901157A1 (ru) Конденсированные кольцевые гетероциклические модуляторы киназы
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
NO20090628L (no) Pyridizinon derivativater
NO20074823L (no) Rasagilin-formuleringer med forbedret innholdsensartethet
MA32257B1 (fr) Hydroxymethyl pyrrolidines comme agonistes des recepteurs beta-3- adrenergiques.
EA200900023A1 (ru) Применение замещенных 2-аминотетралинов для изготовления лекарственного средства для предупреждения, облегчения и/или лечения разных видов боли
MA32161B1 (fr) Formes de rifaximine et utilisations de celles-ci
EA201190235A1 (ru) Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750
NO20074275L (no) 2- (4-okso-4H-kinazolin-3-yl) acetamider og deres anvendelse som Vasopressin-V3-antagonister
NO20090295L (no) Substituerte heteroarylderivater
ATE502921T1 (de) Substituierte indole
CL2008003848A1 (es) Compuestos derivados de fenilo o heteroarilo bis-sulfonilamino sustituidos, inhibidores de prostaglandina e sintasa-1 microsomal; composicion farmaceutica; procedimiento de preparacion; procedimiento de preparacion de la composicion farmaceutica; y uso en el tratamiento del dolor agudo o cronico, dolor nociceptivo o dolor neuropatico.
EA200870185A1 (ru) Комбинации ингибиторов ang2 и vegf
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства
CL2008001367A1 (es) Compuestos derivados de heterociclos nitrogenados sustituidos; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una infeccion bacteriana.
NO20091395L (no) Nye tiofenderivater
ATE472529T1 (de) Prolinamidderivate als natriumkanalmodulatoren
ATE410424T1 (de) Spirocyclische cyclohexan-derivate
EA201001332A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
MX2009003227A (es) Moduladores de los receptores de glutamato metabotropicos 5(mglur5).
JO2682B1 (en) Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application